Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Amitiza, RU-0211, SPI-0211, Lubiprostone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Takeda Pharma Ordered To Pay $2.5 Billion In Amitiza Case
    Takeda Pharma Ordered To Pay $2.5 Billion In Amitiza Case

    21 May 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/takeda-pharma-ordered-to-pay-25-billion-in-amitiza-case-20288

    INDPHARMAPOST
    21 May 2026
    Share Share
    US Jury Finds Takeda Ran Antitrust Scheme to Delay Generic Drug
    US Jury Finds Takeda Ran Antitrust Scheme to Delay Generic Drug

    18 May 2026

    // REUTERS

    https://www.reuters.com/world/takeda-engaged-antitrust-scheme-delay-generic-constipation-drug-us-jury-finds-2026-05-18/

    REUTERS
    18 May 2026
    Share Share
    Lowey Notifies Payors of Amitiza Generics Class Action
    Lowey Notifies Payors of Amitiza Generics Class Action

    09 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lowey-dannenberg-pc-announces-notice-of-class-action-if-you-paid-for-some-or-all-of-the-purchase-price-of-amitiza-and-or-generic-versions-of-amitiza-as-a-third-party-payor-302706947.html

    PR NEWSWIRE
    09 Mar 2026
    Share Share
    Towa Receives Manufacturing & Marketing Approval for Generic Drug
    Towa Receives Manufacturing & Marketing Approval for Generic Drug

    16 Feb 2026

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release260216.pdf

    PRESS RELEASE
    16 Feb 2026
    Share Share
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US

    02 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218640

    FDA
    02 Jan 2025
    Share Share
    Takeda hit with another pay-for-delay lawsuit
    Takeda hit with another pay-for-delay lawsuit

    13 Apr 2023

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/takeda-hit-another-pay-delay-lawsuit-time-colcrys

    Eric Sagonowsky FIERCE PHARMA
    13 Apr 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.